Insight Molecular Diagnostics Inc. — Director's Dealing 2023

Apr 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oncocyte Corp (OCX)
CIK: 0001642380
Period of Report: 2023-04-03

Reporting Person: Arno Andrew (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-03	Common Stock, no par value	A	141084	$0.3544	Acquired	673133	Direct
2023-04-03	Common Stock, no par value	A	141084	$0.3544	Acquired	156084	Indirect
2023-04-03	Common Stock, no par value	A	141084	$0.3544	Acquired	156084	Indirect

Footnotes

F1: These shares of the Issuer's common stock, no par value ("Common Stock"), are held by JBA Investments LLC ("JBA"). The Reporting Person is the Manager of JBA and in such capacity has the right to vote and dispose of securities held by JBA.

F2: These shares of Common Stock are held by MJA Investments LLC ("MJA"). The Reporting Person is the Manager of MJA and in such capacity has the right to vote and dispose of securities held by MJA.